Table 2.

Patients’ demographic data and clinical profile.

Gender	Age	Diagnosis	Medication	Age of onset	Duration of illness
Female	57	F 32.1	Reboxetine, Citalopram	33	24
Female	54	F 33.1	Venlafaxine	50	5
Female	33	F 33.2	Venlafaxine	30	3
Female	34	F 32.1	Citalopram	24	10
Female	49	F 33.2	Venlafaxine, Quetiapine, Lithium carbonate	25	24
Female	33	F 33.3	Venlafaxine, Quetiapine	12	21
Female	33	F 32.1	Fluoxetine	33	1
Female	51	F 33.1	Agomelatine, Duloxetine	46	5
Female	27	F 32.2	Venlafaxine, Mirtazapine	21	6
Female	22	F 32.1	Venlafaxine	13	9
Female	26	F 32.1	Duloxetine	23	3
Female	31	F 33.1	Citalopram	11	20
Female	50	F 33.2	Duloxetine, Quetiapine	47	3
Female	38	F 33.1	Reboxetine	34	4
Female	30	F 32.1	“none”	30	1
Female	51	F 33.1	Escitalopram	31	20
Female	41	F 32.1	Venlafaxine	33	8
Female	29	F 32.2	Citalopram	29	1
Female	42	F 33.1	Mirtazapine	26	16
Male	45	F 32.1	Venlafaxine, Trimipramine	43	2
Male	55	F 33.2	Mirtazapine, Quetiapine, Duloxetine, Pipamperone	49	6
Male	37	F 33.1	Venlafaxine	35	2
Male	46	F 32.1	Venlafaxine, Opipramol	40	6
Male	52	F 32.1	Venlafaxine	44	8
Male	43	F 32.1	Mirtazapine	19	24
Male	27	F 32.1	Reboxetine	24	3
Male	25	F 32.1	Sertraline	21	4
Male	40	F 32.1	Venlafaxine	38	2
Male	30	F 33.1	Citalopram, Lithium	21	9
Male	38	F 32.1	Venlafaxine	35	3
Male	29	F 32.1	Lithium carbonate	24	5
Male	19	F 32.1	Citalopram	16	3
Male	28	F 33.2	Venlafaxine	27	1
Male	30	F 33.1	Opipramol, Sertraline, Mirtazapine	29	1
Male	53	F 33.2	Venlafaxine, Mirtazapine	44	9
Male	34	F 33.2	Venlafaxine, Quetiapine	25	9
Male	22	F 32.1	Venlafaxine	18	4
Male	41	F 33.1	Venlafaxine	36	5
Male	29	F 33.1	Bupropion, Quetiapine	20	9
Male	18	F 32.2	Remergil, Venlafaxine	17	1
Male	24	F 33.1	Citalopram	16	8

Data for age of onset of depression and duration of illness is taken from self-reported information by the patients. Age, age of onset, and duration of illness are specified in years.